Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar 12;2(5):e118.
doi: 10.1002/hsr2.118. eCollection 2019 May.

Natural history of human papillomavirus and vaccinations in men: A literature review

Affiliations
Review

Natural history of human papillomavirus and vaccinations in men: A literature review

Benjamin J Lieblong et al. Health Sci Rep. .

Abstract

Background and aims: Infection with high-risk (HR) genotypes of the human papillomavirus (HPV) is necessary for and causative of almost all cervical cancers and their precursor condition, cervical intraepithelial neoplasia. These conditions have been sharply reduced by cervical cytology screening, and a further decrease is expected because of the recent introduction of prophylactic HPV vaccinations. While significant attention has been given to gynecologic HPV disease, men can be affected by HPV-related cancers of the anus, penis, and oropharynx. This literature review aims to address disparities in HPV-related disease in men, and certain HR male subpopulations, compared with women.

Discussion: Overall, immunocompetent men are far less likely than women to develop anogenital HPV-related cancers, despite harboring HR HPV infections at anogenital sites. On the other hand, men who have sex with men and men living with human immunodeficiency virus infection are at considerably higher risk of HPV-related disease. Historic rates of prophylactic HPV vaccination in males have trailed those of females due to numerous multilevel factors, although, in recent years, this sex gap in vaccination coverage has been closing. In the absence of routine HPV screening in males, therapeutic vaccinations have emerged as a potential treatment modality for preinvasive neoplasia and are in various phases of clinical testing.

Conclusion: Successful reductions in HPV disease morbidity at the population level must acknowledge and target HPV infections in men.

Keywords: human papillomavirus; men; prophylactic vaccination; therapeutic vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that there is no conflict of interest.

Figures

Figure 1
Figure 1
Seroprevalence of HPV 16 in patients of various subpopulations. HPV 16 seroprevalence, defined as positive detection of anti‐HPV 16 antibodies, in patients of various subpopulations. Dashed lines delineate subpopulation comparisons in each cluster of three studies. Reported values are percentage of patients seropositive for HPV 16 in each study. HPV, human papillomavirus; MSM, men who have sex with men; MSW, men who have sex with women

References

    1. Parkin DM. The global health burden of infection‐associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030‐3044. 10.1002/ijc.21731 - DOI - PubMed
    1. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. 1997;102:3‐8. https://doi.org/S0002-9343(97)00177-0 - PubMed
    1. Parkin DM, Bray F. Chapter 2: the burden of HPV‐related cancers. Vaccine. 2006;24(SUPPL. 3):11‐25. 10.1016/j.vaccine.2006.05.111 - DOI - PubMed
    1. Marrazzo JM, Koutsky LA, Kiviat NB, Kuypers JM, Stine K. Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women. Am J Public Health. 2001;91(6):947‐952. 10.2105/AJPH.91.6.947 - DOI - PMC - PubMed
    1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet‐tieulent J, Jemal A. Global Cancer Statistics, 2012. CA Cancer J Clin. 2015;65(2):87‐108. 10.3322/caac.21262 - DOI - PubMed

LinkOut - more resources